PMA supplement
P190002 S019: Saluda Medical Evoke® SCS System
FDA PMA supplement · Panel Track · Saluda Medical Pty, Ltd.
Key facts
| Original PMA | P190002 |
|---|---|
| Supplement number | S019 |
| Supplement type | Panel Track |
| Reason for the supplement | Labeling Change - Indications/instructions/shelf life/tradename |
| Trade name | Saluda Medical Evoke® SCS System |
| Generic name | Stimulator, spinal-cord, totally implanted for pain relief |
| Applicant | Saluda Medical Pty, Ltd. |
| Product code | LGW |
| Received date | Sep 22, 2023 |
| Decision date | Mar 20, 2024 |
| Docket number | 24M-2534 |
| Notice date | May 24, 2024 |
At a glance
- No Expedited review granted
- Yes Approval order on file
- Yes Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: